This inventor holds 2 USPTO granted patents. Top assignee: University of Michigan. Active years: 1991-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ann Arbor, MI (US) (1991)
- Ypsilanti, MI (US) (2009)
Company Filing History:
Years Active: 1991-2009
Title: The Innovative Contributions of David L. Gildersleeve in Nuclear Medicine
Introduction: David L. Gildersleeve is an influential inventor based in Ypsilanti, Michigan, renowned for his contributions to the field of nuclear medicine. With two patents to his name, his innovative work focuses on advanced imaging agents that enhance diagnostic capabilities.
Latest Patents: Gildersleeve's latest patents include significant advancements in imaging agents. The first patent details novel compounds intended for use as imaging agents within nuclear medicine applications, specifically in Positron Emission Tomography (PET) imaging and Single Photon Emission Computed Tomography (SPECT) imaging. This invention also introduces imaging compositions and methods of imaging that aim to improve diagnostic accuracy. His second patent revolves around radioiodinated benzovesamicol analogs, which selectively localize in presynaptic cholinergic neurons, facilitating cholinergic nerve mapping. These analogs can serve as radiopharmaceuticals, enabling visualization of cholinergic neurons with conventional imaging devices commonly found in nuclear medicine and radiology clinics.
Career Highlights: Gildersleeve’s career is marked by his commitment to advancing medical imaging technologies. His innovative work contributes to enhancing the diagnostic landscape in nuclear medicine, providing healthcare professionals with essential tools for accurate patient assessment.
Collaborations: Throughout his career, David L. Gildersleeve has collaborated with esteemed colleagues, including Yong-Woon Jung and Donald M. Wieland. These collaborations underscore the importance of teamwork and shared expertise in driving innovation within the field of medical research.
Conclusion: David L. Gildersleeve represents a significant figure in the advancement of nuclear medicine through his pioneering patents and collaborations. His work not only showcases his inventive prowess but also highlights the critical role of innovation in transforming healthcare diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile